A commentary on the first international conference on engineered vaccines for cancer and AIDS; the "coming of age" of tumor immunology.
Ada
G
G
John Curtin School of Medical Research, Australian National University, Canberra.
D016915:AIDS Vaccines; D000818:Animals; D000943:Antigens, Differentiation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000737:chemistry / Q000145:classification / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology; D016207:Cytokines / Q000627:therapeutic use; D000939:Epitopes / Q000276:immunology; D006001:Glycoconjugates / Q000276:immunology; D006801:Humans; D007157:Immunologic Surveillance; D009363:Neoplasm Proteins / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010446:Peptide Fragments / Q000008:administration & dosage / Q000138:chemical synthesis / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014611:Vaccination / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D016915:AIDS Vaccines; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D001324:Autoantigens; D016207:Cytokines; D000939:Epitopes; D006001:Glycoconjugates; D009363:Neoplasm Proteins; D010446:Peptide Fragments; D014612:Vaccines; D014614:Vaccines, Synthetic